| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.22 | 0.2 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.23 | 0.2 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.23 | 0.2 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |